Posts in Patient Resources
- Home
- Category "Patient Resources"
- (Page 3)
At Austin CyberKnife, we want our patients and their families to feel comfortable with our staff and services. Below is an overview of our center and the treatment we provide.
For patients seeking support for a new diagnosis, building relationships with other patients and hearing from survivors can be a motivational and uplifting experience. The AVM Survivors Network is a support group for patients with arteriovenous malformations, or defects to the circulatory system commonly found in the brain and spinal cord. The network aims to […]
Learn More
Lung tumors, prostate cancer, and brain tumors are among our center’s most frequently treated diseases, yet the CyberKnife® can also treat other diseases through stereotactic body radiation therapy. Arteriovenous Malformation (AVM): AVMs are abnormal connections between arteries and veins that commonly occur in the brain and spine. Blood typically enters the brain through arteries, moves […]
Learn More
The Kidney Cancer Association and Lotsa Helping Hands, an online community network, recently announced a new partnership to support caregivers of patients with kidney cancer through free online caring communities. The service enables a family member, friend, colleague, or neighbor to create an online community to organize help for kidney cancer caregivers day-to-day and during […]
Learn More
Determining a diagnosis and seeking treatment are important steps in the process of healing, but support from friends and loved ones can have the biggest impact on a patient’s quality of life. Living With TN is an online support group for trigeminal neuralgia (TN) patients with the mission to be a resource for “information, discussion, […]
Learn More
CyberKnife® has several benefits including shorter treatment times, no need for incision or sedation and minimal side effects. Below, Austin CyberKnife medical director Dr. Doug Rivera further explains the CyberKnife® treatment process and unique qualities of our center.